Sight Sciences, Inc. (SGHT)
8.80
+0.55
(+6.67%)
USD |
NASDAQ |
Oct 15, 16:00
8.80
0.00 (0.00%)
After-Hours: 20:00
Sight Sciences Cash from Operations (TTM) : -23.24M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.24M |
| March 31, 2026 | -25.12M |
| December 31, 2025 | -29.69M |
| September 30, 2025 | -31.09M |
| June 30, 2025 | -22.01M |
| March 31, 2025 | -24.17M |
| December 31, 2024 | -22.35M |
| September 30, 2024 | -25.61M |
| June 30, 2024 | -35.80M |
| March 31, 2024 | -39.59M |
| December 31, 2023 | -47.18M |
| September 30, 2023 | -56.20M |
| Date | Value |
|---|---|
| June 30, 2023 | -66.57M |
| March 31, 2023 | -71.38M |
| December 31, 2022 | -75.96M |
| September 30, 2022 | -71.18M |
| June 30, 2022 | -67.50M |
| March 31, 2022 | -61.64M |
| December 31, 2021 | -52.54M |
| September 30, 2021 | -50.37M |
| June 30, 2021 | -42.47M |
| March 31, 2021 | -35.48M |
| December 31, 2020 | -32.17M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Integra LifeSciences Holdings Corp. | 85.33M |
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.673M |
| Alphatec Holdings, Inc. | 56.52M |
| AtriCure, Inc. | 64.94M |